Abstract

The protein kinases are a large family of enzymes that play fundamental roles in propagating signals within the cell. Because of the high degree of binding site similarity shared among protein kinases, designing drug compounds with high specificity among the kinases has proven difficult. However, computational approaches to comparing the 3-dimensional geometry and physicochemical properties of key binding site residue positions have been shown to be informative of inhibitor selectivity. The Combinatorial Clustering Of Residue Position Subsets (ccorps) method, introduced here, provides a semi-supervised learning approach for identifying structural features that are correlated with a given set of annotation labels. Here, ccorps is applied to the problem of identifying structural features of the kinase atp binding site that are informative of inhibitor binding. ccorps is demonstrated to make perfect or near-perfect predictions for the binding affinity profile of 8 of the 38 kinase inhibitors studied, while only having overall poor predictive ability for 1 of the 38 compounds. Additionally, ccorps is shown to identify shared structural features across phylogenetically diverse groups of kinases that are correlated with binding affinity for particular inhibitors; such instances of structural similarity among phylogenetically diverse kinases are also shown to not be rare among kinases. Finally, these function-specific structural features may serve as potential starting points for the development of highly specific kinase inhibitors.

Highlights

  • The protein kinases constitute the largest enzyme family encoded by the human genome, with currently 518 known sequences, making up 1.7% of all human genes [1,2]

  • The high degree of binding site similarity shared across the protein kinases has made them difficult targets for which to design highly selective inhibitors, but kinome-wide binding site analysis can help predict unintended off-target inhibitions

  • The Combinatorial Clustering Of Residue Position Subsets (CCORPS) method is introduced and used to synthesize kinome-wide structure datasets with a kinome-wide inhibitor affinity screening dataset consisting of 38 kinase inhibitors

Read more

Summary

Introduction

The protein kinases constitute the largest enzyme family encoded by the human genome, with currently 518 known sequences, making up 1.7% of all human genes [1,2]. The large number of disease states found to be associated with kinase dysregulation has motivated the development of kinase-specific inhibitor compounds and research to discover protein kinase inhibitors has come to constitute 20–30% of the drug development programs at many companies [1]. The bulk of this effort has been directed at identifying inhibitors that bind at the ATP binding site. By binding to the allosteric site, type II inhibitors are able to make additional highly specific interactions, thereby allowing them to be more selective [3]

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.